Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13101)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Croagh CM, Lubel JS. Natural history of chronic hepatitis B: Phases in a complex relationship. World J Gastroenterol 2014; 20(30): 10395-10404 [PMID: 25132755 DOI: 10.3748/wjg.v20.i30.10395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10395.htm |
| Number | Citing Articles |
| 1 |
Jixia Li, Jinya Xu, Yangui Wang, Qin Li, Xilian Sun, Wen Fu, Bo Zhang. Association of Nucleostemin Polymorphisms with Chronic Hepatitis B Virus Infection in Chinese Han Population. Genetic Testing and Molecular Biomarkers 2022; 26(5): 255 doi: 10.1089/gtmb.2021.0181
|
| 2 |
Janett Fischer, Eleni Koukoulioti, Eckart Schott, Balazs Fülöp, Renate Heyne, Thomas Berg, Florian van Bömmel. Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31065-6
|
| 3 |
Junping Zhu, Tong Zhang, Lina Cao, Aixin Li, Kai Zheng, Nan Zhang, Bin Su, Zhiyun Chen, Ning Chen, Hao Wu, Qiushui He. Toll like receptor7 polymorphisms in relation to disease susceptibility and progression in Chinese patients with chronic HBV infection. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12698-5
|
| 4 |
Tawatchai Apidechkul. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3747-3
|
| 5 |
Xianbo Wang, Yuxin Li, Fangyuan Gao. Chronic Hepatitis B: Could a Noninvasive Scoring Model Help Predict Therapy outcomes?. Future Virology 2018; 13(3): 155 doi: 10.2217/fvl-2017-0140
|
| 6 |
Prakriti Sinha, Vaishali Bhardwaj, Abaranjitha Muniyasamy, K. Varsha Mohan, Kshama Jain, Kiran Chaudhary, Pramod Upadhyay. Monocyte Transcriptome in Different Phases of Chronic Hepatitis B Virus Infection Uncovers Potential Functional Roles. Viral Immunology 2024; 37(6): 287 doi: 10.1089/vim.2024.0006
|
| 7 |
Yong Kwang Park, Sun Young Lee, Ah Ram Lee, Kyung‐Chang Kim, Kisoon Kim, Kyun‐Hwan Kim, Byeong‐Sun Choi. Antiviral activity of interferon‐stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter. Journal of Gastroenterology and Hepatology 2020; 35(8): 1426 doi: 10.1111/jgh.14986
|
| 8 |
Yi Xu, ShuangJie Li, WenXian OuYang, Zhenzhen Yao, Xin Lai, Yingping Gu, Meng Yang, Ling Ye, Sisi Li, Songxu Peng. Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1380771
|
| 9 |
Daniel Castaneda, Adalberto Jose Gonzalez, Mohammad Alomari, Kanwarpreet Tandon, Xaralambos Bobby Zervos. From hepatitis A to E: A critical review of viral hepatitis. World Journal of Gastroenterology 2021; 27(16): 1691-1715 doi: 10.3748/wjg.v27.i16.1691
|
| 10 |
Derouiche Samir, Hammadi Nour, Chouia Maroua. Assessment of Haematological Complications and Prognostic Value of Oxidative Stress Markers in Viral Hepatitis B Patients. Journal of Medical Sciences 2022; 22(2): 44 doi: 10.3923/jms.2022.44.52
|
| 11 |
Xiongfei Chen, Lishuang Ding, Deshuai Kong, Xiulei Zhao, Lili Liao, Yaomin Zhang, Fengshan Li, Ruhai Liu. FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis. Open Life Sciences 2020; 15(1): 259 doi: 10.1515/biol-2020-0027
|
| 12 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
|
| 13 |
Orçun Barkay, Serpil Erol, Seniha Senbayrak. Unraveling the Complexity of Atypical Serological Profiles in Chronic Hepatitis B: Insights Into Disease Dynamics and Clinical Implications. Cureus 2023; doi: 10.7759/cureus.44899
|
| 14 |
Enebe Joseph Tochukwu, Enebe Nympha Onyinye, Onwujekwe Emmanuel Obinna. Assessing the awareness and acceptability of hepatitis B immunoglobulin among pregnant women in Enugu metropolis, Southeast, Nigeria: A cross-sectional study. SAGE Open Medicine 2024; 12 doi: 10.1177/20503121241257083
|
| 15 |
Jianming Hu, You-Yu Lin, Pei-Jer Chen, Koichi Watashi, Takaji Wakita. Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development. Gastroenterology 2019; 156(2): 338 doi: 10.1053/j.gastro.2018.06.093
|
| 16 |
|
| 17 |
Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, Gerardo Guillen, Euduaro Penton, Angela Tuero, Osamu Yoshida, Yoichi Hiasa, Morikazu Onji, Vincent Wong. Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial). PLOS ONE 2018; 13(8): e0201236 doi: 10.1371/journal.pone.0201236
|
| 18 |
Minghui Li, Yuanjiao Gao, Liu Yang, Yanjie Lin, Wen Deng, Tingting Jiang, Xiaoyue Bi, Yao Lu, Lu Zhang, Ge Shen, Ruyu Liu, Shuling Wu, Min Chang, Mengjiao Xu, Leiping Hu, Rui Song, Yuyong Jiang, Wei Yi, Yao Xie. Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1024333
|
| 19 |
Ummi Maimunah, Puspa Wardhani, Citrawati Dyah Kencono Wungu, Anisa Firdausi Rahmanda, Andreas Agung Kurniawan, Andrio Palayukan. Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00336-5
|
| 20 |
Seyed Moayed Alavian, Mohammad Hadi Imanieh, Mohammad Hossein Imanieh. Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections. Hepatitis Monthly 2016; 16(5) doi: 10.5812/hepatmon.34790
|
| 21 |
Forough Golsaz-Shirazi, Fazel Shokri. Hepatitis B Immunopathogenesis and Immunotherapy. Immunotherapy 2016; 8(4): 461 doi: 10.2217/imt.16.3
|
| 22 |
Beatriz Lozano-Ruiz, José M. González-Navajas. The Emerging Relevance of AIM2 in Liver Disease. International Journal of Molecular Sciences 2020; 21(18): 6535 doi: 10.3390/ijms21186535
|
| 23 |
Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You. Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients. Clinical and Molecular Hepatology 2023; 29(3): 747 doi: 10.3350/cmh.2023.0121
|
| 24 |
RENGANG HUANG, NAN JIANG, RENGUO YANG, XIAOXIA GENG, JIANMEI LIN, GANG XU, DANDAN LIU, JIDOG CHEN, GUO ZHOU, SHUQIANG WANG, TINGTING LUO, JIAZHEN WU, XIAOSHU LIU, KAIJU XU, XINGXIANG YANG. Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B. Experimental and Therapeutic Medicine 2016; 11(5): 1673 doi: 10.3892/etm.2016.3135
|
| 25 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Revista de Gastroenterología de México (English Edition) 2021; 86(4): 403 doi: 10.1016/j.rgmxen.2021.04.002
|
| 26 |
Eun-Jeong Joo, Hae Suk Cheong, Min-Jung Kwon, Won Sohn, Han-Na Kim, Yong Kyun Cho. Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00461-1
|
| 27 |
Ming-hui Li, Yao Lu, Fang-fang Sun, Qi-qi Chen, Lu Zhang, Hui-hui Lu, Zhan Zeng, Wei Yi, Yao Xie. Transforming growth factor β as a possible independent factor in chronic hepatitis B. Archives of Virology 2021; 166(7): 1853 doi: 10.1007/s00705-021-05062-6
|
| 28 |
Amina A. Negash, Michael Gale. Hepatitis regulation by the inflammasome signaling pathway. Immunological Reviews 2015; 265(1): 143 doi: 10.1111/imr.12279
|
| 29 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B. Revista de Gastroenterología de México 2021; 86(4): 403 doi: 10.1016/j.rgmx.2021.04.002
|
| 30 |
Tran Thanh Tung, Jürgen Schmid, Vu Xuan Nghia, Le Chi Cao, Le Thi Kieu Linh, Ikrormi Rungsung, Bui Tien Sy, Truong Nhat My, Nguyen Trong The, Nghiem Xuan Hoan, Christian G. Meyer, Heiner Wedemeyer, Peter G. Kremsner, Nguyen Linh Toan, Le Huu Song, C.-Thomas Bock, Thirumalaisamy P. Velavan. Low Risk of Occult Hepatitis B Infection among Vietnamese Blood Donors. Pathogens 2022; 11(12): 1524 doi: 10.3390/pathogens11121524
|
| 31 |
Lihong Shen, Yun Zhang, Min Shi, Lijia Shao, Shengchun Feng, Weiting Li, Zhonggang Fang, Jun Yin, Tinghua Li. Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay. Journal of Medical Virology 2024; 96(7) doi: 10.1002/jmv.29817
|
| 32 |
Stanca M Ciupe. Modeling the dynamics of hepatitis B infection, immunity, and drug therapy. Immunological Reviews 2018; 285(1): 38 doi: 10.1111/imr.12686
|
| 33 |
Yuqian Luo, Le Zhang, Yimin Dai, Yali Hu, Biyun Xu, Yi-Hua Zhou. Conservative Evolution of Hepatitis B Virus Precore and Core Gene During Immune Tolerant Phase in Intrafamilial Transmission. Virologica Sinica 2020; 35(4): 388 doi: 10.1007/s12250-020-00194-6
|
| 34 |
Fareed Ghulam, Noval Zakaria, Muhammad Ibrahim Majeed, Faisal Ismail. Viral Hepatitis - The Road Traveled and the Journey Remaining. Hepatic Medicine: Evidence and Research 2022; : 13 doi: 10.2147/HMER.S352568
|
| 35 |
Khalid Alswat, Riham Soliman, Nabiel N. H. Mikhail, Necati Örmeci, George N. Dalekos, Moutaz F. M. Derbala, Said Ahmed Al-Busafi, Waseem Hamoudi, Gamal Shiha. Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B. Saudi Journal of Gastroenterology 2024; 30(3): 138 doi: 10.4103/sjg.sjg_27_24
|
| 36 |
Shalini Sakthivel, L. Preethi, Prudhvi Lal Bhukya. Emerging Human Viral Diseases, Volume II. 2024; : 509 doi: 10.1007/978-981-97-4480-0_19
|
| 37 |
Zhan-Qing Zhang, Wei Lu, Yan-Bing Wang, Qi-Cheng Weng, Zhi-Yong Zhang, Zhi-Qiang Yang, Yan-Ling Feng. Measurement of the hepatitis B core-related antigen is valuable for predicting the pathological status of liver tissues in chronic hepatitis B patients. Journal of Virological Methods 2016; 235: 92 doi: 10.1016/j.jviromet.2016.05.016
|
| 38 |
Krzysztof Domagalski, Małgorzata Pawłowska, Agnieszka Zaleśna, Małgorzata Pilarczyk, Paweł Rajewski, Waldemar Halota, Andrzej Tretyn. Impact of IL28B and <i>OAS</i> gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus. World Journal of Gastroenterology 2016; 22(41): 9186-9195 doi: 10.3748/wjg.v22.i41.9186
|
| 39 |
甜静 张. Advances in Antiviral Therapy for Hepatitis B Cirrhosis in the Compensated Stage. Advances in Clinical Medicine 2024; 14(04): 41 doi: 10.12677/acm.2024.144985
|
| 40 |
Edina Amponsah-Dacosta. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?. World Journal of Gastroenterology 2021; 27(36): 6025-6038 doi: 10.3748/wjg.v27.i36.6025
|
| 41 |
KGHeBTA (King George's Medical University Hepatitis B Therapeutic Algorithm): A New Diagnostic and Therapeutic Algorithm and Clinico-epidemiological Spectrum of Hepatitis B. Journal of Clinical and Experimental Hepatology 2023; 13(4): 629 doi: 10.1016/j.jceh.2023.02.007
|
| 42 |
Xiangjun Zhai, Liguo Zhu, Jie Jiang, Ci Song, Hong Peng, Jiao Qian, MingHao Zhou, Yan Zhou, Qungang Wang, Jianfang Xu, Zhijian Wang, Hongjian Liu, Min Fan, Zhibin Hu, Hongbin Shen, Fengcai Zhu. Virological activity in treatment-naïve HBeAg-negative HBV-infected adult patients. Medicine 2020; 99(29): e21179 doi: 10.1097/MD.0000000000021179
|
| 43 |
Daniela Păcurar, Alexandru Dinulescu, Gheorghiță Jugulete, Alexandru-Sorin Păsărică, Irina Dijmărescu. Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania. Life 2024; 14(3): 348 doi: 10.3390/life14030348
|
| 44 |
Dede Sit, Bennur Esen, Ahmet Engin Atay, Hasan Kayabaşı. Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy. World Journal of Hepatology 2015; 7(5): 761-768 doi: 10.4254/wjh.v7.i5.761
|
| 45 |
Wen-Tao Wang, Xue-Qi Zhao, Gui-Ping Li, Yi-Zhi Chen, Lin Wang, Mei-Fang Han, Wei-Na Li, Tao Chen, Guang Chen, Dong Xu, Qin Ning, Xi-Ping Zhao. Immune response pattern varies with the natural history of chronic hepatitis B. World Journal of Gastroenterology 2019; 25(16): 1950-1963 doi: 10.3748/wjg.v25.i16.1950
|
| 46 |
Jingyu Zhao, Xinyue Zhang, Liwei Fang, Hong Pan, Jun Shi. Association between IL28B Polymorphisms and Outcomes of Hepatitis B Virus Infection: A meta-analysis. BMC Medical Genetics 2020; 21(1) doi: 10.1186/s12881-020-01026-w
|
| 47 |
Ersin AKGÖLLÜ. Effect of FOXP3 gene variants on the immune-active HBV and inactive HBV phases. Cukurova Medical Journal 2021; 46(4): 1485 doi: 10.17826/cumj.978353
|
| 48 |
Elfatih Hamida Mohammed, Mohammed Raja Saud, Seyoum Yemane, Elkhidir Isam Mohammed, Tekle Freweini. Serological and virological profile of patients with chronic hepatitis B infection in Eritrea. International Journal of Clinical Virology 2020; 4(1): 095 doi: 10.29328/journal.ijcv.1001022
|
| 49 |
Amie Ceesay, Khaled Bouherrou, Boun Kim Tan, Maud Lemoine, Gibril Ndow, Barbara Testoni, Isabelle Chemin. Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries. Microorganisms 2022; 10(11): 2096 doi: 10.3390/microorganisms10112096
|
| 50 |
Michelle R. Paulsen, Nikitha R. Patel, Carol Sulis, Francis A. Farraye, Shubha Bhat. Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists. Journal of Pharmacy Practice 2021; 34(6): 943 doi: 10.1177/0897190020958261
|
| 51 |
Mark K. Webale, Valentine Budambula, Raphael Lihana, Francis O. Musumba, Anthony K. Nyamache, Nancy L. M. Budambula, Aabid A. Ahmed, Collins Ouma, Tom Were. Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-1060-3
|
| 52 |
Y. Lv, M. Cui, Z. Lv, J. Lu, X. Zhang, Z. Zhao, Y. Wang, L. Gao, N.M. Tsuji, H. Yan. Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients. Clinics and Research in Hepatology and Gastroenterology 2018; 42(5): 462 doi: 10.1016/j.clinre.2018.04.002
|
| 53 |
Wen-Chun Liu, I-Chin Wu, Yen-Cheng Chiu, Kuo-Chih Tseng, Chi-Yi Chen, Hung-Chih Chiu, Pin-Nan Cheng, Ting-Tsung Chang. Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients. Antiviral Research 2020; 176: 104719 doi: 10.1016/j.antiviral.2020.104719
|
| 54 |
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1135 doi: 10.1080/17474124.2023.2268503
|
| 55 |
D. V. Tserashkou, V. M. Mitsura. Chronic hepatitis B virus infection: clinical characteristics and antiviral therapy. Health and Ecology Issues 2022; 19(2): 82 doi: 10.51523/2708-6011.2022-19-2-10
|
| 56 |
Taegeun Lee, John Jeongseok Yang, Jinseok Eom, Sohee Kwon, Borae G. Park, Sang-Hyun Hwang, Heung-Bum Oh. A single-center, single-blind study to evaluate the clinical sensitivity, specificity, and agreement between Elecsys Anti-HBc II and Elecsys Anti-HBc in a Korean population. Journal of Clinical Virology 2018; 109: 41 doi: 10.1016/j.jcv.2018.10.009
|
| 57 |
Penglei Ge, Huayu Yang, Jingfen Lu, Wenjun Liao, Shunda Du, Yingli Xu, Haifeng Xu, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Jiefu Huang, Yilei Mao. Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5120760
|
| 58 |
Kefang Yao, Jiacheng Liu, Jian Wang, Xiaomin Yan, Juan Xia, Yue Yang, Weihua Wu, Yong Liu, Yuxin Chen, Zhaoping Zhang, Jie Li, Rui Huang, Chao Wu. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone. Journal of Viral Hepatitis 2021; 28(7): 1025 doi: 10.1111/jvh.13511
|
| 59 |
Meilan Cui, Ying Lv, Jianhua Lu, Wei Zhang, Yuanyuan Duan, Yan Huang, Lei Yang, Man Li, Wenxuan Liu, Dianwu Liu, Huimin Yan. Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection. Journal of Clinical Laboratory Analysis 2018; 32(2) doi: 10.1002/jcla.22246
|
| 60 |
William R. Treem, Melissa Palmer, Isabelle Lonjon-Domanec, Daniel Seekins, Lara Dimick-Santos, Mark I. Avigan, John F. Marcinak, Ajit Dash, Arie Regev, Eric Maller, Meenal Patwardhan, James H. Lewis, Don C. Rockey, Adrian M. Di Bisceglie, James W. Freston, Raul J. Andrade, Naga Chalasani. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Safety 2021; 44(2): 133 doi: 10.1007/s40264-020-01014-2
|
| 61 |
Maya Rosenberg, Maria Poluch, Colin Thomas, Paola Sindaco, Alan Khoo, Pierluigi Porcu. Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1275800
|
| 62 |
Aya Raed Alheany, Shatha Farouk Abdullah. Status of HBeAg in association with other baseline tests in Iraqi patients with CHB. Research Journal of Pharmacy and Technology 2022; : 3475 doi: 10.52711/0974-360X.2022.00582
|
| 63 |
Kukwah Anthony Tufon, Damian Nota Anong, Henry Dilonga Meriki, Teuwafeu Denis Georges, Mouladje Maurice, Youmbi Sylvain Kouanou, Ayah Flora Bolimo, Nyeke James Tony, Tebit Emmanuel Kwenti, Ndze Henry Wung, Theresa Nkuo-Akenji, Isabelle Chemin. Characterization and assessment of HBV chronically infected patients: Identification of those eligible for treatment in the South West region of Cameroon. PLOS ONE 2018; 13(9): e0203312 doi: 10.1371/journal.pone.0203312
|
| 64 |
Vahdat Poortahmasebi, Ali Salarian, Mehdi Amiri, Mansour Poorebrahim, Seyed Mohammad Jazayeri, Atousa Ataei, Matin Asghari, Seyed Moayed Alavian. Integrated Analysis of Gene Expression Profiles Reveals Deregulation of the Immune Response Genes during Different Phases of Chronic Hepatitis B Infection. Hepatitis Monthly 2017; 17(3) doi: 10.5812/hepatmon.42237
|
| 65 |
Carla S. Coffin, Samuel S. Lee. New paradigms in hepatitis B management: only diamonds are forever. British Medical Bulletin 2015; : ldv039 doi: 10.1093/bmb/ldv039
|
| 66 |
Chun-yan Yao, Zhao-suo Hu, Run-lin Yuan, Juan Jin, Zheng-xu Chen. CD32 Expression by CD4+ T and CD8+ T Lymphocytes Is Increased in Patients with Chronic Hepatitis B Virus Infection. Viral Immunology 2023; 36(5): 351 doi: 10.1089/vim.2022.0183
|
| 67 |
Hong-Sheng Yu, Hao Jiang, Ming-Kai Li, Bi-Lan Yang, Abdukyamu Smayi, Jian-Ning Chen, Bin Wu, Yi-Dong Yang. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World Journal of Gastroenterology 2023; 29(35): 5166-5177 doi: 10.3748/wjg.v29.i35.5166
Abstract(450) |
Core Tip(512) |
Full Article(HTML)(1607)
|
Full Article with Cover (PDF)-2471K(88)
|
Full Article (Word)-894K(37)
|
Audio-1337K(2)
|
Peer-Review Report-228K(52)
|
Answering Reviewers-99K(41)
|
Supplementary Material-264K(53)
|
Full Article (PDF)-1434K(132)
|
Full Article (XML)-113K(43)
|
Times Cited (4)
|
Total Visits (5602)
|
Open
|
| 68 |
Min Zhang, Jing Li, Zhiqiang Xu, Peiyao Fan, Yi Dong, Fuchuan Wang, Yinjie Gao, Jianguo Yan, Lili Cao, Dong Ji, Danni Feng, Yanwei Zhong, Yang Zhang, Weiguo Hong, Chao Zhang, Fu-Sheng Wang. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B. Hepatology International 2024; 18(2): 435 doi: 10.1007/s12072-023-10631-9
|
| 69 |
Keerthana Raja, Sembiyaa Arumugam, Sheik S.S.J. Ahmed, Ramakrishnan Veerabathiran. Oncogenic Viruses. 2023; : 197 doi: 10.1016/B978-0-12-824152-3.00006-8
|
| 70 |
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang, Bin Wu. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1079495
|
| 71 |
Marina Manea, Dimitri Apostol, Ileana Constantinescu. A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B Virus. Diagnostics 2023; 13(22): 3425 doi: 10.3390/diagnostics13223425
|
| 72 |
Simone Lanini, Raffaella Pisapia, Maria Rosaria Capobianchi, Giuseppe Ippolito. Global epidemiology of viral hepatitis and national needs for complete control. Expert Review of Anti-infective Therapy 2018; 16(8): 625 doi: 10.1080/14787210.2018.1505503
|
| 73 |
Oluwadamilola Gideon Osasona, Opeoluwa Adewale-Fashoro, Testimony J. Olumade, Judith Oguzie, Uwem George, Olumuyiwa Elijah Ariyo, Oluwatosin Oluwagbenga Oguntoye. Comparative serologic profiles of hepatitis B Virus (HBV) between HIV/HBV co-infected and Hbv mono-infected patients in Ile-Ife, Nigeria. Journal of Immunoassay and Immunochemistry 2021; 42(6): 633 doi: 10.1080/15321819.2021.1924197
|
| 74 |
Shanshan Chen, Xuan Dai, Yueyue Zhao, Jie Li, Xuehan Zou, Haijun Huang, Eiji Sakai. Clinical Distribution Characteristics and Identification for Significant Liver Inflammation of Patients in Chronic Hepatitis B with Indeterminate Phase. Gastroenterology Research and Practice 2023; 2023: 1 doi: 10.1155/2023/7264601
|
| 75 |
Desalegn Weldebrhan, Hailemariam Berhe, Yohannes Tesfay. Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case–Control Study. Hepatic Medicine: Evidence and Research 2023; : 79 doi: 10.2147/HMER.S407069
|
| 76 |
Si-Biao Su, Shan-Yu Qin, Xiao-Long Xian, Fei-Fei Huang, Qiu-Lan Huang, Han-Jing ZhangDi, Hai-Xing Jiang. Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis. Life Sciences 2021; 264: 118677 doi: 10.1016/j.lfs.2020.118677
|
| 77 |
Ashish Kumar Vyas, Mojahidul lslam, Garima Garg, Anirudh K. Singh, Nirupma Trehanpati. Humoral Immune Responses and Hepatitis B Infection. Digestive Diseases 2021; 39(5): 516 doi: 10.1159/000514274
|
| 78 |
J. Huang, Q. You, D. Song, X. Rong, C. Li, Y. Fu. Update on epidemiology of hepatitis B virus among blood donors in China. ISBT Science Series 2018; 13(3): 359 doi: 10.1111/voxs.12432
|
| 79 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
| 80 |
Teresa I. Ng, Patrick K. Dorr, Preethi Krishnan, Daniel E. Cohen, Susan Rhee, Stanley X. Wang, Melanie C. Ruzek, Federico J. Mensa, Warren M. Kati. Biomarkers for the clinical development of antiviral therapies. Cytometry Part B: Clinical Cytometry 2021; 100(1): 19 doi: 10.1002/cyto.b.21974
|
| 81 |
Mohammed Elfatih Hamida, Saud Mohammed Raja, Yemane Seyoum, Isam Mohammed Elkhidir, Freweini Tekle. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01789-3
|
| 82 |
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann. Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancers 2024; 16(4): 777 doi: 10.3390/cancers16040777
|
| 83 |
Yingfu Zeng, Jiwei Huang, Jiahui Pang, Shufang Pan, Yuankai Wu, Yusheng Jie, Xinhua Li, Yutian Chong. The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1330644
|